Andelyn Biosciences Partners with Celliaz for Gene Therapy Manufacturing
- Andelyn Biosciences has partnered with Celliaz to manufacture CLZ002, an investigational gene therapy for retinitis pigmentosa.
- The collaboration will utilize Andelyn's AAV Curator® Suspension Platform for end-to-end development and manufacturing services.
Operational Impact
This partnership enhances Andelyn's capacity in gene therapy manufacturing, supporting the advancement of CLZ002 through clinical trials.
Source: PharmaSource RSS